Larotrectinib

ATC L01EX12 · 7 markets · 26 records

Larotrectinib 7 markets · 26 records Forms

US 7 records · 3 strengths

100 mgcapsuleVITRAKVI also in GB·AU·ES +1
25 mgcapsuleVITRAKVI also in GB·AU·ES +1
20 mgliquidVITRAKVI also in GB·TW

GB 4 records · 3 strengths

100 mgcapsuleVITRAKVI also in US·AU·ES +1
25 mgcapsuleVITRAKVI also in US·AU·ES +1
20 mgliquidVitrakvi 20mg/ml oral solution also in US·TW

AU 4 records · 4 strengths

100 mgcapsuleVITRAKVI also in US·GB·ES +1
25 mgcapsuleVITRAKVI also in US·GB·ES +1
20 mg/1 mLliquidVITRAKVI also in ES

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名VITRAKVI ×7

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

ES 3 records · 3 strengths

100 mgcapsuleVITRAKVI also in US·GB·AU +1
25 mgcapsuleVITRAKVI also in US·GB·AU +1
20 mg/1 mLliquidVITRAKVI also in AU

TW 3 records · 3 strengths

100 mgcapsuleVITRAKVI+1維泰凱膠囊100毫克 also in US·GB·AU +1
25 mgcapsuleVITRAKVI+1維泰凱膠囊25毫克 also in US·GB·AU +1
20 mgliquidVitrakvi 20mg/ml oral solution+1維泰凱20毫克/毫升口服溶液 also in US·GB

HK 3 records · 1 strengths

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名VITRAKVI ×14Vitrakvi 20mg/ml oral solution ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名VITRAKVI ×7

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	AU	ES	TW	HK	EU
100 mg capsule	VITRAKVI	VITRAKVI	VITRAKVI	VITRAKVI	VITRAKVI 維泰凱膠囊100毫克	not recorded	not recorded
25 mg capsule	VITRAKVI	VITRAKVI	VITRAKVI	VITRAKVI	VITRAKVI 維泰凱膠囊25毫克	not recorded	not recorded
20 mg liquid	VITRAKVI	Vitrakvi 20mg/ml oral solution	not recorded	not recorded	Vitrakvi 20mg/ml oral solution 維泰凱20毫克/毫升口服溶液	not recorded	not recorded
20 mg/1 mL liquid	not recorded	not recorded	VITRAKVI	VITRAKVI	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	VITRAKVI	not recorded	not recorded	VITRAKVI Vitrakvi 20mg/ml oral solution	VITRAKVI

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.